Jiangxi Haoran Bio-Pharma Co., Ltd. | Urokinase (UK)
HomeMailboxContact Us

Products Sort

15079574576371870.jpg

Urokinase (UK)

Current Location : HomePage > Products
Urokinase (UK)
Urokinase (UK) is a thrombolytic agent extracted from human fresh urine. It can activate plasminogen to plasmin, with the subsequent hydrolysis of fibrin and dissolution of thrombi.

 

This product is mainly used in the treatment of acute myocardial infarction, acute cerebral thrombosis, occlusion of cerebral blood vessel, peripheral arteriovenous thrombi, central retinal arteriovenous thrombi and other infarction diseases due to freshly formed clot

 

Haoran Biopharma can supply bulk UK with the following specifications. Products of various specifications can also be prepared according to customers' requests.


 

Appearance
White or almost white, amorphous powder
Identification
Identified
Activity
Not less than 80,000 IU/mg
Specific activity
Not less than 120,000 IU/mg protein
Clarity of solution
Clear
Thromboplastic contaminants
Not less than 150 IU/ml
HMW-Urokinase
Not less than 90%
Bacterial endotoxins
Not more than 1.0 EU /10,000 IU
Abnormal toxicity
Negative at 5000 IU/0.5ml/mouse
HIV I+II antibody
Negative
Hepatitis B surface antigen
Negative
HCV antibodies
Negative